189 related articles for article (PubMed ID: 10551393)
1. Concanavalin A-binding cholesterol crystallization inhibiting and promoting activity in bile from patients with Crohn's disease compared to patients with ulcerative colitis.
Keulemans YC; Mok KS; Slors JF; Brink MA; Gouma DJ; Tytgat GN; Groen AK
J Hepatol; 1999 Oct; 31(4):685-91. PubMed ID: 10551393
[TBL] [Abstract][Full Text] [Related]
2. Gallbladder bile composition in patients with Crohn 's disease.
Lapidus A; Akerlund JE; Einarsson C
World J Gastroenterol; 2006 Jan; 12(1):70-4. PubMed ID: 16440420
[TBL] [Abstract][Full Text] [Related]
3. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease.
Brink MA; Slors JF; Keulemans YC; Mok KS; De Waart DR; Carey MC; Groen AK; Tytgat GN
Gastroenterology; 1999 Jun; 116(6):1420-7. PubMed ID: 10348826
[TBL] [Abstract][Full Text] [Related]
4. Biliary lipid composition in patients with nonoperated Crohn's disease.
Rutgeerts P; Ghoos Y; Vantrappen G; Fevery J
Dig Dis Sci; 1986 Jan; 31(1):27-32. PubMed ID: 3940821
[TBL] [Abstract][Full Text] [Related]
5. The role of the Concanavalin A-binding fraction in cholesterol crystallization in native human bile.
Keulemans YC; Mok KS; Gouma DJ; Groen AK
J Hepatol; 1997 Dec; 27(6):1041-50. PubMed ID: 9453430
[TBL] [Abstract][Full Text] [Related]
6. Effects of colectomy on bile composition, cholesterol saturation and cholesterol crystal formation in humans.
Akerlund JE; Einarsson C
Int J Colorectal Dis; 2000 Aug; 15(4):248-52. PubMed ID: 11008727
[TBL] [Abstract][Full Text] [Related]
7. Bile composition in inflammatory bowel disease: ileal disease and colectomy, but not colitis, induce lithogenic bile.
Pereira SP; Bain IM; Kumar D; Dowling RH
Aliment Pharmacol Ther; 2003 Apr; 17(7):923-33. PubMed ID: 12656695
[TBL] [Abstract][Full Text] [Related]
8. Increased activity in the biliary Con A-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients.
Miquel JF; Van Der Putten J; Pimentel F; Mok KS; Groen AK
Hepatology; 2001 Feb; 33(2):328-32. PubMed ID: 11172333
[TBL] [Abstract][Full Text] [Related]
9. BODY COMPOSITION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS.
Back IR; Marcon SS; Gaino NM; Vulcano DSB; Dorna MS; Sassaki LY
Arq Gastroenterol; 2017; 54(2):109-114. PubMed ID: 28198913
[TBL] [Abstract][Full Text] [Related]
10. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery.
Gustafsson U; Benthin L; Granström L; Groen AK; Sahlin S; Einarsson C
Hepatology; 2005 Jun; 41(6):1322-8. PubMed ID: 15834935
[TBL] [Abstract][Full Text] [Related]
11. Differences in the immunoglobulin synthesis by peripheral blood lymphocytes in Crohn's disease and ulcerative colitis.
Verspaget HW; Peña AS; Weterman IT; Lamers CB
Digestion; 1987; 38(4):245-53. PubMed ID: 3447918
[TBL] [Abstract][Full Text] [Related]
12. No pathophysiologic relationship of soluble biliary proteins to cholesterol crystallization in human bile.
Wang DQ; Cohen DE; Lammert F; Carey MC
J Lipid Res; 1999 Mar; 40(3):415-25. PubMed ID: 10064729
[TBL] [Abstract][Full Text] [Related]
13. Lectin histochemistry in ulcerative colitis and Crohn's disease.
Yoshioka H; Inada M; Ogawa K; Ohshio G; Yamabe H; Hamashima Y; Miyake T
J Exp Pathol; 1989; 4(2):69-78. PubMed ID: 2769448
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile.
Van Erpecum KJ; Portincasa P; Eckhardt E; Go PM; VanBerge-Henegouwen GP; Groen AK
Gastroenterology; 1996 Apr; 110(4):1225-37. PubMed ID: 8613013
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fecal granulocyte excretion in ulcerative colitis and Crohn's colitis.
Saverymuttu SH; Hodgson HJ; Chadwick VS
Dig Dis Sci; 1984 Nov; 29(11):1000-4. PubMed ID: 6489079
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol microcrystals associated with concanavalin A-binding glycoproteins contribute artifactually to nucleating activity assays.
Harvey PR; Upadhya GA; Strasberg SM
J Lipid Res; 1995 Dec; 36(12):2661-9. PubMed ID: 8847492
[TBL] [Abstract][Full Text] [Related]
17. Effects of a concanavalin A-binding biliary glycoprotein on nucleation time of gallbladder bile.
Nakano A; Masuzawa S; Ogura K; Fukazawa S; Nakamoto K; Sekido H; Fukushima T; Tsuchiya S
Gastroenterol Jpn; 1990 Feb; 25(1):88-92. PubMed ID: 2307338
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
19. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
[TBL] [Abstract][Full Text] [Related]
20. Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis?
Pereira SP; Rhodes JM; Campbell BJ; Kumar D; Bain IM; Murphy GM; Dowling RH
Clin Sci (Lond); 1998 Nov; 95(5):637-44. PubMed ID: 9791051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
